335 research outputs found
Effect of dietary fish oil on blood levels of free fatty acids, ketone bodies and triacylglycerol in humans
Although the reduction of serum triacylglycerol concentrations by dietary fish oil is a well-known effect, the exact mechanism of this effect has not been previously studied in human subjects. Therefore, the aim of this study was (i) to examine the effect of short-term fish oil supplementation on blood concentrations of ketone bodies, free fatty acids and triacylglycerol in healthy humans and (ii) to verify whether the observed relationships between these variables would be consistent with reduced lipolysis and/or enhanced hepatic fatty acid oxidation after fish oil supplementation. Twenty subjects (21-23 years, normal liver function tests) were randomly divided into two groups to supplement their usual diet with either 30 g/d of fish oil (n=11) or olive oil (n=9). Venous blood samples were drawn after an overnight fast, before and after 1, 3 and 7 d of fish oil/olive oil supplementation. Blood concentrations of triacylglycerol and free fatty acids decreased consistently after fish oil supplementation; the reduction was already significant after one day of fish oil (P0.10). No significant changes in glucose, insulin or ketone body levels were observed in either group after supplementation. After fish oil, but not after olive oil supplementation, the ratio of blood ketone body levels to free fatty acid levels increased significantly (P<0.05). Furthermore, after fish oil supplementation only, free fatty acid levels were significantly correlated with levels of ketone bodies (day 7 of supplementation: r=0.90, P<0.001) and triacylglycerol (maximum value on day 3: r=0.77, P<0.01). These findings suggest that reduced lipolysis and increased hepatic β-oxidation/ketogenesis may contribute to reduced triacylglycerol levels after ω3 fatty acid supplementation in humans. Turnover studies are needed in order to further quantitate these processes
The impact of delirium on the prediction of in-hospital mortality in intensive care patients
Introduction: predictive models, such as acute physiology and chronic health evaluation II (APACHE-II), are widely used in intensive care units (ICUs) to estimate mortality. Although the presence of delirium is associated with a higher mortality in ICU patients, delirium is not part of the APACHE-II model. The aim of the current study was to evaluate whether delirium, present within 24 hours after ICU admission, improves the predictive value of the APACHE-II score.Methods: in a prospective cohort study 2116 adult patients admitted between February 2008 and February 2009 were screened for delirium with the confusion assessment method-ICU (CAM-ICU). Exclusion criteria were sustained coma and unable to understand Dutch. Logistic regression analysis was used to estimate the predicted probabilities in the model with and without delirium. Calibration plots and the Hosmer-Lemeshow test (HL-test) were used to assess calibration. The discriminatory power of the models was analyzed by the area under the receiver operating characteristics curve (AUC) and AUCs were compared using the Z-test.Results: 1740 patients met the inclusion criteria, of which 332 (19%) were delirious at the time of ICU admission or within 24 hours after admission. Delirium was associated with in-hospital mortality in unadjusted models, odds ratio (OR): 3.22 (95% confidence interval [CI]: 2.23 - 4.66). The OR between the APACHE-II and in-hospital mortality was 1.15 (95% CI 1.12 - 1.19) per point. The predictive accuracy of the APACHE-II did not improve after adding delirium, both in the total group as well as in the subgroup without cardiac surgery patients. The AUC of the APACHE model without delirium was 0.77 (0.73 - 0.81) and 0.78 (0.74 - 0.82) when delirium was added to the model. The z-value was 0.92 indicating no improvement in discriminative power, and the HL-test and calibration plots indicated no improvement in calibration.Conclusions: although delirium is a significant predictor of mortality in ICU patients, adding delirium as an additional variable to the APACHE-II model does not result in an improvement in its predictive estimate
Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer
BACKGROUND: Extracellular adenosine 5'-triphosphate (ATP) is involved in
the regulation of a variety of biologic processes, including
neurotransmission, muscle contraction, and liver glucose metabolism, via
purinergic receptors. In nonrandomized studies involving patients with
different tumor types including non-small-cell lung cancer (NSCLC), ATP
infusion appeared to inhibit loss of weight and deterioration of quality
of life (QOL) and performance status. We conducted a randomized clinical
trial to evaluate the effects of ATP in patients with advanced NSCLC
(stage IIIB or IV). METHODS: Fifty-eight patients were randomly assigned
to receive either 10 intravenous 30-hour ATP infusions, with the infusions
given at 2- to 4-week intervals, or no ATP. Outcome parameters were
assessed every 4 weeks until 28 weeks. Between-group differences were
tested for statistical significance by use of repeated-measures analysis,
and reported P values are two-sided. RESULTS: Twenty-eight patients were
allocated to receive ATP treatment and 30 received no ATP. Mean weight
changes per 4-week period were -1.0 kg (95% confidence interval [CI] =
-1.5 to -0.5) in the control group and 0.2 kg (95% CI = -0.2 to +0.6) in
the ATP group (P =.002). Serum albumin concentration declined by -1.2 g/L
(95% CI= -2.0 to -0.4) per 4 weeks in the control group but remained
stable (0.0 g/L; 95% CI = -0.3 to +0.3) in the ATP group (P =.006). Elbow
flexor muscle strength declined by -5.5% (95% CI = -9.6% to -1. 4%) per 4
weeks in the control group but remained stable (0.0%; 95% CI= -1.4% to
+1.4%) in the ATP group (P =.01). A similar pattern was observed for knee
extensor muscles (P =.02). The effects of ATP on body weight, muscle
strength, and albumin concentration were especially marked in cachectic
patients (P =.0002, P =.0001, and P =. 0001, respectively, for ATP versus
no ATP). QOL score changes per 4-week period in the ATP group showed
overall less deterioration than in the control group-physical scores
(-0.2% versus -2.4%; P =. 0002); functional scores (+0.4% versus -5.5%; P
=.02); psychologic scores (-0.7% versus -2.4%; P =.11); overall QOL score
(+0.1% versus -3.5%; P =.0001). CONCLUSIONS: This randomized trial
demonstrates that ATP has beneficial effects on weight, muscle strength,
and QOL in patients with advanced NSCLC
Dietary exposure to polychlorinated biphenyls and dioxins from infancy until adulthood: A comparison between breast-feeding, toddler, and long-term exposure
Food is the major source for polychlorinated biphenyl (PCB) and dioxin
accumulation in the human body. Therefore, investigating food habits from
early ages until reproductive age (25 years) is important in order to
assess exposure risk for the next generation. The objective of this study
was to assess the PCB/dioxin exposure and the relative contribution of
different foods to total exposure during preschool age. Particularly, the
importance of lactational PCB/dioxin exposure vs. dietary exposure until
adulthood was investigated. A cohort of 207 children was studied from
birth until preschool age. Based on 3 planar PCBs and 17
2,3,7,8-substituted dibenzo-para-dioxins (PCDDs) and dibenzofurans (PCDFs)
measured in breast milk, a model was developed to calculate the cumulative
toxic equivalent (TEQ) intake during breast-feeding (0-1 year). In 3.
5-year-old children, daily dietary intake of planar PCB-TEQ and dioxin-TEQ
was measured with a validated food questionnaire. Cumulative TEQ intake
from 1 to 5 years was estimated using the PCB- and dioxin-TEQ intake
measured with the food questionnaire. Cumulative TEQ intake from 6 to 25
years was estimated using national food consumption and contamination data
of PCB- and dioxin-TEQ intake. In toddlers, dairy products contributed 43%
to PCB-TEQ and 50% to dioxin-TEQ intake. Meat and meat products
contributed 14% and 19%, respectively, and processed foods 23% and 15%,
respectively. Breast-feeding for 6 months contributed to the cumulative
PCB/dioxin TEQ intake until 25 years of age, 12% in boys and 14% in girls.
The daily TEQ intake per kilogram body weight is 50 times higher in
breast-fed infants and three times higher in toddlers than in adults.
Long-term dietary exposure to PCBs and dioxins in men and women is partly
due to breast-feeding (12 and 14%, respectively). After weaning, dairy
products, processed foods, and meat are major contributors of PCB and
dioxin accumulation until reproductive age. Instead of discouraging
breast-feeding, maternal transfer of PCBs and dioxins to the next
generation must be avoided by enforcement of strict regulations for PCB
and dioxin discharge and by reducing consumption of animal products and
processed foods in all ages
SAR interferometry at Venus for topography and change detection
AbstractSince the Magellan radar mapping of Venus in the early 1990’s, techniques of synthetic aperture radar interferometry (InSAR) have become the standard approach to mapping topography and topographic change on Earth. Here we investigate a hypothetical radar mission to Venus that exploits these new methods. We focus on a single spacecraft repeat-pass InSAR mission and investigate the radar and mission parameters that would provide both high spatial resolution topography as well as the ability to detect subtle variations in the surface. Our preferred scenario is a longer-wavelength radar (S or L-band) placed in a near-circular orbit at 600km altitude. Using longer wavelengths minimizes the required radar bandwidth and thus the amount of data that will be transmitted back to earth; it relaxes orbital control and knowledge requirements. During the first mapping cycle a global topography map would be assembled from interferograms taken from adjacent orbits. This approach is viable due to the slow rotation rate of Venus, causing the interferometric baseline between adjacent orbits to vary from only 11km at the equator to zero at the inclination latitude. To overcome baseline decorrelation at lower latitudes, the center frequency of a repeated pass will be adjusted relative to the center frequency of its reference pass. During subsequent mapping cycles, small baseline SAR acquisitions will be used to search for surface decorrelation due to lava flows. While InSAR methods are used routinely on Earth, their application to Venus could be complicated by phase distortions caused by the thick Venus atmosphere
A systematic review of methods to assess intake of fruits and vegetables among healthy European adults and children: a DEDIPAC (DEterminants of DIet and Physical Activity) study
Evidence suggests that health benefits are associated with consuming recommended amounts of fruits and vegetables (F&V), yet standardised assessment methods to measure F&V intake are lacking. The current review aims to identify methods to assess F&V intake among children and adults in pan-European studies and inform the development of the DEDIPAC (DEterminants of DIet and Physical Activity) toolbox of methods suitable for use in future European studies.
A literature search was conducted using three electronic databases and by hand-searching reference lists. English-language studies of any design which assessed F&V intake were included in the review.
Studies involving two or more European countries were included in the review.
Healthy, free-living children or adults.
The review identified fifty-one pan-European studies which assessed F&V intake. The FFQ was the most commonly used (n 42), followed by 24 h recall (n 11) and diet records/diet history (n 7). Differences existed between the identified methods; for example, the number of F&V items on the FFQ and whether potatoes/legumes were classified as vegetables. In total, eight validated instruments were identified which assessed F&V intake among adults, adolescents or children.
The current review indicates that an agreed classification of F&V is needed in order to standardise intake data more effectively between European countries. Validated methods used in pan-European populations encompassing a range of European regions were identified. These methods should be considered for use by future studies focused on evaluating intake of F&V
Weight loss and elevated gluconeogenesis from alanine in lung cancer patients
BACKGROUND: The role of gluconeogenesis from protein in the pathogenesis
of weight loss in lung cancer is unclear. OBJECTIVE: Our aim was to study
gluconeogenesis from alanine in lung cancer patients and to analyze its
relation to the degree of weight loss. DESIGN: In this cross-sectional
study, we used primed-constant infusions of [6,6-(2)H(2)]-D-glucose and
[3-(13)C]-L-alanine to assess whole-body glucose and alanine turnover and
gluconeogenesis from alanine in weight-losing (WL, n = 9) and
weight-stable (WS, n = 10) lung cancer patients and healthy control (n =
15) subjects. RESULTS: Energy intake and plasma alanine concentrations did
not differ significantly among the subject groups. Mean (+/-SEM)
whole-body glucose production was significantly higher in WL than in WS
and control subjects (0.74 +/- 0.06 compared with 0.55 +/- 0.04 and 0.51
+/- 0.04 mmol*kg(-)(1)*h(-)(1), respectively, P < 0.01). Alanine turnover
was significantly elevated in WL compared with WS and control subjects
(0.57 +/- 0.04 compared with 0.42 +/- 0.05 and 0.40 +/- 0.03
mmol*kg(-)(1)*h(-)(1), respectively, P < 0.01). Gluconeogenesis from
alanine was significantly higher in WL than in WS and control subjects
(0.47 +/- 0.04 compared with 0.31 +/- 0.04 and 0.29 +/- 0.04
mmol*kg(-)(1)*h(-)(1), respectively, P < 0.01). The degree of weight loss
was positively correlated with glucose and alanine turnover and with
gluconeogenesis from alanine (r = 0.45 for all, P < 0.01). CONCLUSIONS:
Aberrant glucose and alanine metabolism occurred in WL lung cancer
patients. These changes were related to the degree of weight loss and not
to the presence of lung cancer per se
The association of early life socioeconomic conditions with prediabetes and type 2 diabetes: results from the Maastricht study
markdownabstractBackground: Using cross-sectional data from The Maastricht Study, we examined the association of socioeconomic conditions in early life with prediabetes and T2DM in adulthood. We also examined potential mediating pathways via both adulthood socioeconomic conditions and adult BMI and health behaviours.
Methods: Of the 3263 participants (aged 40-75 years), 493 had prediabetes and 906 were diagnosed with T2DM. By using logistic regression analyses, the associations and possible mediating pathways were examined.
Results: Participants with low early life socioeconomic conditions had a 1.56 times higher odds of prediabetes (95% confidence interval (CI) = 1.21-2.02) and a 1.61 times higher odds of T2DM (95% CI = 1.31-1.99). The relation between low early life socioeconomic conditions and prediabetes was independent of current socioeconomic conditions (OR = 1.38, 95% CI = 1.05-1.80), whereas the relation with T2DM was not independent of current socioeconomic conditions (OR = 1.10, 95% CI = 0.87-1.37). BMI party mediated the association between early life socioeconomic conditions and prediabetes.
Conclusions: Socioeconomic inequalities starting in early life were associated with diabetes-related outcomes in adulthood and suggest the usefulness of early life interventions aimed at tackling these inequalities
Blood pressure variability in individuals with and without (pre)diabetes:the Maastricht Study
Objective: The mechanisms associating (pre)diabetes and cardiovascular disease (CVD) are incompletely understood. We hypothesize that greater blood pressure variability (BPV) may underlie this association, due to its association with (incident) CVD. Therefore, we investigated the association between (pre)diabetes and very short-term to mid-term BPV, that is within-visit, 24-h and 7-day BPV. Methods: Cross-sectional data from The Maastricht Study [normal glucose metabolism (NGM), n¼1924; prediabetes, n¼511; type 2 diabetes mellitus (T2DM), n¼975; 51% men, aged 608 years]. We determined SD for within visit BPV (n¼3244), average real variability for 24-h BPV (n¼2699) day (0900–2100 h) and night (0100–0600 h) separately, and SD for 7-day BPV (n¼2259). Differences in BPV as compared with NGM were assessed by multiple linear regressions with adjustment for potential confounders. Results: In T2DM, the average systolic/diastolic values of within-visit, 24-h and 7-day BPV were 4.8/2.6, 10.5/7.3 and 10.4/6.5 mmHg, respectively, and in prediabetes 4.9/ 2.6, 10.3/7.0 and 9.4/5.9 mmHg, respectively. T2DM was associated with greater nocturnal systolic BPV [0.42mmHg (95% confidence interval: 0.05–0.80)], and greater 7-day systolic [0.76mmHg (0.32–1.19)] and diastolic BPV [0.65mmHg (0.29–1.01)], whereas prediabetes was associated with greater within-visit systolic BPV only [0.35mmHg (0.06–0.65)], as compared with NGM. Conclusion: Both T2DM and prediabetes are associated with slightly greater very short-term to mid-term BPV, which may, according to previous literature, explain a small part of the increased CVD risk seen in (pre)diabetes. Nevertheless, these findings do not detract from the fact that very short-term to mid-term BPV is substantial and important in individuals with and without (pre)diabetes
- …